Alterations in coagulation after implantation of a pulsatile novacor LVAD and the axial flow micromed DeBakey LVAD

Annals of Thoracic Surgery

Volumn 70, Issue 2, 2000, Pages 533-537

  Koster, Andreas ^a   Loebe, Matthias ^a   Hansen, Roland ^a   Potapov, Evgenij V ^a   Noon, George P ^a   Kuppe, Hermann ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ANTIPLASMIN; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 12A; COUMARIN DERIVATIVE; D DIMER; DIPYRIDAMOLE; HEPARIN; PLASMIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; CELL DAMAGE; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; HEART ASSIST DEVICE; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; PULSATILE FLOW; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM;

ADULT; ANTIPLASMIN; ANTITHROMBIN III; ANTITHROMBINS; BETA-THROMBOGLOBULIN; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; EQUIPMENT DESIGN; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLATELET FACTOR 4; POSTOPERATIVE PERIOD;

EID: 0033840644     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01404-1     Document Type: Article

References (18)

1. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
2. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology
3. Success rates of long-term assist devices used currently for bridge to heart transplantation
4. HeartMate left ventricular assist device as bridge to heart transplantation
5. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation including the new wearable system
6. Increased activation of the coagulation and fibrinolytic systems lead to hemorrhagic complications during left ventricular assist implantation
7. Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device
8. Complement activation in patients undergoing mechanical circulatory support
9. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device
10. High incidence of left ventricular thrombosis and systemic embolism in patients with left ventricular assist system
11. Development of a non-pulsatile permanent rotary blood pump
12. Platelet morphology in patients with mechanical circulatory support
13. Platelet damage caused by the centrifugal pump: In vitro evaluation by measuring the release of alpha-granule packing proteins
14. Inhibition of the activation of Hagemann factor (factor XII) by platelet factor 4
15. Platelets inhibit fibrinolysis in vitro by both plasminogen activator-1-inhibitor-dependent and-independent mechanisms
16. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture
17. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices
18. Hemostatic profiles of HeartMate ventricular assist device recipients